Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/bjo.2008.144402 http://scihub22266oqcxt.onion/10.1136/bjo.2008.144402 C4397565!4397565 !18829634     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18829634 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\18829634 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Br+J+Ophthalmol 2008 ; 92 (12 ): 1653-5 Nephropedia Template TP {{tp|p=18829634 |t=2008. Hydroxychloroquine retinopathy screening |pdf=|usr=}}{{18829634 }} gab.com Text Hydroxychloroquine retinopathy screening JO: Br J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=18829634 #FOAvip AIM: To compare current hydroxychloroquine retinopathy screening practices with the published 2002 American Academy of Ophthalmology (AAO) Preferred Practice Patterns (PPP). METHODS: A multiple-choice survey was distributed to 105 ophthalmologists to assess current screening practices and knowledge of patient risk factors. Results were compared with the PPP guidelines. A cost analysis of the PPP and survey paradigms was conducted. RESULTS: Sixty-seven (64%) of 105 surveys were completed. The majority (90%) of physicians screen for hydroxychloroquine retinopathy with either central automated threshold perimetry or Amsler grid as recommended by the PPP. Most survey respondents could not correctly identify the evidence-based risk factors. The majority screen more frequently than recommended: 87% screen high-risk patients and 94% screen low-risk patients more frequently than recommended in the PPP. The increased screening frequency of low-risk patients translates into an excess of $44 million in the first 5 years of therapy. If all patients were screened using exact PPP paradigm, savings could exceed $150 million every 10 years. CONCLUSIONS: Ophthalmologists currently screen for hydroxychloroquine retinopathy correctly; however, their lack of familiarity with evidence-based guidelines may result in excessive follow-up. Increasing awareness and implementation of the PPP could potentially reduce hydroxychloroquine retinopathy screening costs significantly. Twit Text FOAVip Hydroxychloroquine retinopathy screening ????Br J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=18829634 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=18829634 #FOAvip English Wikipedia <ref>{{Cite pmid|18829634 }}</ref> Hydroxychloroquine retinopathy screening #MMPMID18829634 Semmer AE ; Lee MS ; Harrison AR ; Olsen TW Br J Ophthalmol 2008[Dec]; 92 (12 ): 1653-5 PMID18829634 show ga AIM: To compare current hydroxychloroquine retinopathy screening practices with the published 2002 American Academy of Ophthalmology (AAO) Preferred Practice Patterns (PPP). METHODS: A multiple-choice survey was distributed to 105 ophthalmologists to assess current screening practices and knowledge of patient risk factors. Results were compared with the PPP guidelines. A cost analysis of the PPP and survey paradigms was conducted. RESULTS: Sixty-seven (64%) of 105 surveys were completed. The majority (90%) of physicians screen for hydroxychloroquine retinopathy with either central automated threshold perimetry or Amsler grid as recommended by the PPP. Most survey respondents could not correctly identify the evidence-based risk factors. The majority screen more frequently than recommended: 87% screen high-risk patients and 94% screen low-risk patients more frequently than recommended in the PPP. The increased screening frequency of low-risk patients translates into an excess of $44 million in the first 5 years of therapy. If all patients were screened using exact PPP paradigm, savings could exceed $150 million every 10 years. CONCLUSIONS: Ophthalmologists currently screen for hydroxychloroquine retinopathy correctly; however, their lack of familiarity with evidence-based guidelines may result in excessive follow-up. Increasing awareness and implementation of the PPP could potentially reduce hydroxychloroquine retinopathy screening costs significantly. |Adult [MESH] |Aged [MESH] |Antirheumatic Agents/*adverse effects [MESH] |Clinical Competence/standards [MESH] |Cost-Benefit Analysis [MESH] |Female [MESH] |Health Care Surveys [MESH] |Humans [MESH] |Hydroxychloroquine/*adverse effects [MESH] |Male [MESH] |Mass Screening/*economics/methods [MESH] |Middle Aged [MESH] |Ophthalmology/standards [MESH] |Practice Guidelines as Topic [MESH] |Practice Patterns, Physicians' [MESH]Hydroxychloroquine retinopathy screening (epmc).pdf DeepDyve Pubget Overpricing